Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05857787 Recruiting - Healthy Clinical Trials

Validation of Educational Effect of Nerve Tracking Function Mounted on the Ultrasound

Start date: July 12, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to find out whether the nerve track function is helpful in distinguishing appropriate anatomical structures for beginners using ultrasound.

NCT ID: NCT05857488 Enrolling by invitation - Healthy Clinical Trials

Feasibility, Safety and Utility of Endomicroscopy to Study the Intestines of Unsedated Infants at University of Virginia (UVa)

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the feasibility of using the transnasal endomicroscopy (TNE) platform, using intestinal potential difference (IPD) and microbiome brush to evaluate the intestine of unsedated infants.

NCT ID: NCT05857449 Completed - Healthy Clinical Trials

An Exploratory Study of LPM3480392 at Different Infusion Rates in Chinese Healthy Subjects

Start date: November 8, 2021
Phase: Phase 1
Study type: Interventional

This study evaluated the safety, tolerability and PK/PD characteristics of LPM3480392 injection by intravenous infusion at different rates in healthy subjects.The experiment was divided into Part A and Part B. Part A is a open label ,three cycle , fixed sequence dosing study .Twelve healthy male subjects were planned to be enrolled, and the same dose (X1mg)of LPM3480392 injection was intravenously injected at different infusion times in different drug administration cycles. Part B is an open label ,two cycle , fixed sequence dosing study .Ten healthy male subjects (subjects not enrolled in Part A) were given LPM3480392 injection in 2 minutes , each subject was given X2mg at the first cycle and X3mg at the second cycle .

NCT ID: NCT05855525 Not yet recruiting - Healthy Clinical Trials

Real-time fMRI for Insular Cortex Brain State-triggered Experience Sampling

Start date: February 15, 2024
Phase: N/A
Study type: Interventional

In a neuroimaging session, study participants will repeatedly and intermittently report the content of their ongoing, self-generated experiences based on an experience-sampling protocol in which self-report ratings will be triggered based on real-time analysis of the participant's current brain state. The protocol will be conducted while participants are undergoing MRI scanning.

NCT ID: NCT05855187 Completed - Healthy Clinical Trials

Bioequivalence Study of Modafinil From Bravamax 200 mg Scored Tablets (Chemipharm Pharmaceutical Industries, Egypt) Versus Vigil 200 mg Tablets (Teva GmbH, Germany)

Start date: November 15, 2022
Phase: Phase 1
Study type: Interventional

Comparative, Randomized, Single Dose, Two-way Crossover Bioequivalence Study to determine the bioequivalence of Modafinil From Bravamax 200 mg Scored Tablets (Chemipharm Pharmaceutical Industries, Egypt) Versus Vigil 200 mg Tablets (Teva GmbH, Germany)

NCT ID: NCT05854771 Completed - Healthy Clinical Trials

Effects Of Yoga Before vs After Eccentric Exercise On Delayed Onset Muscle Soreness

Start date: October 28, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effects of pre and post-exercise yoga after eccentric exercise on delayed onset muscle soreness in healthy adults. The main question it aims to answer is whether there will be a difference in the effects of pre and post-exercise yoga in reducing delayed muscle soreness. The participants will be divided into two groups; group A and group B. Group A will perform single bout of yoga before the eccentric exercise and Group B will perform single bout of yoga after eccentric exercise.

NCT ID: NCT05853341 Completed - Healthy Clinical Trials

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)

Start date: May 2, 2023
Phase: Phase 1
Study type: Interventional

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 13.3 mg/24 h (Luye Pharma AG, Germany) and the marketed Reference product Exelon® 13.3 mg/24 h transdermales Pflaster (Novartis Pharma GmbH, Germany) after multiple patch applications. Each of both treatments will last for 11 days with a washout period of 14 days between the treatments.

NCT ID: NCT05853016 Recruiting - Healthy Clinical Trials

A Urine Sample Collection Study in Apparently Healthy Adults and Adults With Chronic, Stable Morbidities

Start date: March 21, 2022
Phase:
Study type: Observational

The objective of this study is collect urine samples from healthy adult subjects and subjects with stable chronic morbidities for future testing to serve as controls and establish reference ranges in the development of new invitro diagnostic devices.

NCT ID: NCT05850767 Completed - Healthy Clinical Trials

The Effect of Sleep Deprivation on Passive and Active Functions and Distance Modulation of the Vestibulo-Ocular Reflex

Start date: May 19, 2022
Phase: N/A
Study type: Interventional

The goal of this cross-over clinical trial is to evaluate the effect of 24 hours sleep deprivation on the Vestibulo-Ocular Reflex (VOR) in healthy participants. The main questions it aims to answer are: 1. The effect of sleep deprivation on vestibular function. 2. The difference between passive and active VOR function following sleep deprivation. 3. The vergence mediated modulation ability of the VOR following sleep deprivation. 4. The effect of sleep deprivation on behavioral VOR function. Participants will be tested before and after a normal night sleep and during 24 hours of sleep deprivation.

NCT ID: NCT05850754 Active, not recruiting - Healthy Clinical Trials

4 Week Veterans Cannabidiol Intervention

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

Cannabidiol (CBD), a non-psychoactive hemp derivative, is an attractive therapeutic agent, and is most supported by the scientific community as an antiepileptic. Additionally, CBD is also associated with claims related to improvements in overall health, pain, anxiety, depression, and sleep; however, the scientific evidence is lacking. The overarching goal of this investigation is to determine the effects of a 4-week CBD intervention on measures of overall health, pain, anxiety, depression, and sleep in a population of US veterans. Primary aims will explore the effects of 4 weeks of CBD on pain, anxiety, and depression. Secondary aims will determine whether 4 weeks of CBD will affect general measures of overall health and sleep.